Current Opinion in HIV and AIDS was launched in 2006. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of HIV and AIDS are divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Professor Ian Weller is Emeritus Professor of Sexually Transmitted Diseases in the Centre for Sexual Health and HIV Research, Research Department of Infection and Population Health, University College London, UK. His research career began as a UK Medical Research Council Training Fellow at the Royal Free Hospital in London. It continued as a Wellcome Trust Senior Lecturer in Infectious Diseases at University College London, then Professor of Sexually Transmitted diseases and now Professor Emeritus, continuing a special interest in international research in HIV and AIDS.
He is currently Vice Chair of the UKs Commission on Human Medicines and in this capacity he has chaired numerous advisory groups on drug safety issues. He has been the Chair and is now Vice-Chair of the European Medicines Agency's Specialist Advisory Group on HIV and viral diseases and Chair of the UKs Tripartite Working Group on HIV/AIDS and hepatitis which has reviewed the management of health care workers infected with blood borne viruses.
Professor Weller is currently Chair of COHERE a very large European HIV cohort collaboration which is now part of EuroCoord funded by the European Commission.
He is Chair of the Steering Committees of five international trials and studies in HIV/AIDS funded by UKs Medical Research Council and Department of International Development and the EDCTP in Uganda, Zimbabwe, Malawi, Zambia and Kenya.
He is a member of the Scientific Advisory Board to the French AIDS research agency (ANRS), the Strategic Working Group of the Division of AIDS (NIH-USA) and a member of the Independent Scientific Advisory Board of SACORE (a Wellcome Trust funded African consortium initiative, focusing on research career pathway capacity building).
Professor Weller is Chairman of the International Congress on Drug Therapy in HIV Infection which has been held bi-annually since 1992 and on the organising committee of the annual International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV. He was a member and Deputy Chair of a National Health Service ethics committee for 10 years and is currently a member and Chair of several data and safety monitoring committees of international studies. He is currently a Trustee of the HIV Trust which supports scholars from resource poor countries in short term capacity building attachments.
Lisa Maher holds appointments as a Professor in the Faculty of Medicine at the University of New South Wales in Sydney, Australia, Program Head at the Kirby Institute for infection and immunity, Australia, and National Health and Medical Research Council (NHMRC) Senior Research Fellow. She has extensive experience in research, program development and service delivery with drug users, sex workers and people living with HIV in North America, South East Asia, Australia and the Pacific. Her research focuses on the prevention of infectious disease in vulnerable populations and she currently leads a randomised controlled trial of hepatitis B vaccine completion in people who inject drugs and a program of hepatitis C vaccine preparedness studies, including a cohort of anti-HCV negative people who inject drugs. She is also an investigator on longitudinal studies of drug users and female sex workers in Canada, female sex workers in Cambodia, and an international collaboration of cohorts examining acute HIV and HCV infection in people who inject drugs. Professor Maher is also responsible for a national program of viral hepatitis surveillance, including Australia's internationally renowned system for monitoring anti-HIV and anti-HCV prevalence and associated risk behaviour in people who inject drugs.
Nick Walsh is a public health physician with a clinical background in addiction medicine and the treatment of HIV and viral hepatitis among people who inject drugs in Australia and the Asian region. He is a National Health and Medical Research Council PhD scholar with Monash University, Australia. Over the last 10 years he has been involved in the initiation of HIV prevention and opioid substitution programs for people who inject drugs (PWID) in a number of countries including Nepal, Cambodia and the Maldives as well as the Asian regional response to HIV prevention through effective substance use treatment. More recently he has supported integrated models of clinical services to PWID in Cambodia including TB and HIV diagnosis and treatment in the setting of methadone. He is currently involved with the development of global guidance on viral hepatitis for PWID with the World Health Organization.